Details for Patent: 9,522,155
✉ Email this page to a colleague
Title: | Synthetic bile acid compositions and methods |
Abstract: | Bile acids and related compositions and methods of synthesis and use. More specifically, deoxycholic acid and related compositions, said compositions being free of all moieties of animal origin and free of pyrogenic moieties. |
Inventor(s): | Moriarty; Robert M. (Michiana Shores, IN), David; Nathaniel E. (Los Angeles, CA), Mahmood; Nadir Ahmeduddin (Calabasas, CA) |
Assignee: | KYTHERA BIOPHARMACEUTICALS, INC. (Calabasas, CA) |
Filing Date: | Sep 30, 2014 |
Application Number: | 14/503,273 |
Claims: | 1. A composition comprising about 0.1% w/v to about 2% w/v deoxycholic acid (DCA): ##STR00023## or a pharmaceutically acceptable salt thereof, wherein the DCA comprises a synthetic side chain of formula: ##STR00024## and at least one pharmaceutically acceptable excipient and/or carrier. 2. A method for removal of fat deposits in a mammal comprising administering to the mammal in need thereof a therapeutically effective amount of a composition comprising DCA ##STR00025## or a pharmaceutically acceptable salt thereof, wherein the DCA comprises a synthetic side chain of formula: ##STR00026## and at least one pharmaceutically acceptable excipient and/or carrier. 3. The method of claim 2, wherein the composition comprises about 0.1% w/v to about 2% w/v DCA or a pharmaceutically acceptable salt thereof. 4. The method of claim 2, wherein the composition further comprises up to 5% w/v phosphatidylcholine. 5. The method of claim 2, wherein the composition does not contain phosphatidylcholine. 6. A syringe or syringe-loadable container comprising a composition comprising DCA: ##STR00027## or a pharmaceutically acceptable salt thereof, wherein the DCA comprises a synthetic side chain of formula: ##STR00028## and at least one pharmaceutically acceptable excipient and/or carrier. 7. The syringe or syringe-loadable container of claim 6, wherein the composition comprises about 0.1% w/v to about 2% w/v DCA or a pharmaceutically acceptable salt thereof. 8. The syringe or syringe-loadable container of claim 6, wherein the composition further comprises up to 5% w/v phosphatidylcholine. 9. The syringe or syringe-loadable container of claim 6, wherein the composition does not contain phosphatidylcholine. |